US2010069615A1PendingUtilityA1
Regulation of Human Transmembrane Serine Protease
Est. expiryJun 13, 2020(expired)· nominal 20-yr term from priority
A61K 38/00C12N 9/6424
73
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Reagents that regulate human transmembrane serine protease activity and reagents that bind to human transmembrane serine protease gene products can be used to regulate extracellular matrix degradation. Such regulation is particularly useful for treating COPD, metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.
Claims
exact text as granted — not AI-modified1 . A preparation of antibodies that specifically bind to a polypeptide comprising the amino acid sequence shown in SEQ ID NO:12.
2 . The preparation of antibodies of claim 1 which are polyclonal.
3 . The preparation of antibodies of claim 1 which are monoclonal.
4 . The preparation of antibodies of claim 1 which are single-chain antibodies.
5 . A preparation of antibodies that specifically bind to a polypeptide comprising the amino acid sequence encoded by a cDNA insert contained within plasmid pCR11-TMSP3 (ATCC Accession No. PTA-3433).
6 . The preparation of antibodies of claim 5 which are polyclonal.
7 . The preparation of antibodies of claim 5 which are monoclonal.
8 . The preparation of antibodies of claim 5 which are single-chain antibodies.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.